Shalini C Reshmi
Overview
Explore the profile of Shalini C Reshmi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
1092
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gupta S, Rau R, Kairalla J, Rabin K, Wang C, Angiolillo A, et al.
N Engl J Med
. 2024 Dec;
392(9):875-891.
PMID: 39651791
Background: B-cell acute lymphoblastic leukemia (B-cell ALL) is the most common childhood cancer. Despite a high overall cure rate, relapsed B-cell ALL remains a leading cause of cancer-related death among...
2.
Booth K, Schulte R, Smith L, Gao H, Stohler R, Liu Y, et al.
Arch Pathol Lab Med
. 2024 May;
149(2):159-164.
PMID: 38749501
Context.—: Pediatric B-cell acute lymphoblastic leukemia is genetically and phenotypically heterogeneous, with a genetic landscape including chromosomal translocations that disrupt ABL proto-oncogene 1, non-receptor tyrosine kinase (ABL1). Objective.—: To characterize...
3.
Bhat S, Rousseau J, Michaud C, Lourenco C, Stoler J, Louie R, et al.
Am J Hum Genet
. 2024 Mar;
111(4):761-777.
PMID: 38503299
Ion channels mediate voltage fluxes or action potentials that are central to the functioning of excitable cells such as neurons. The KCNB family of voltage-gated potassium channels (Kv) consists of...
4.
Rabin K, Devidas M, Chen Z, Ji L, Kairalla J, Hitzler J, et al.
J Clin Oncol
. 2023 Oct;
42(2):218-227.
PMID: 37890117
Purpose: Patients with Down syndrome (DS) and B-ALL experience increased rates of relapse, toxicity, and death. We report results for patients with DS B-ALL enrolled on Children's Oncology Group trials...
5.
Schieffer K, Moccia A, Bucknor B, Stonerock E, Jayaraman V, Jenkins H, et al.
Cancers (Basel)
. 2023 Sep;
15(17).
PMID: 37686670
Gene fusions are a form of structural rearrangement well established as driver events in pediatric and adult cancers. The identification of such events holds clinical significance in the refinement, prognostication,...
6.
Hunger S, Tran T, Saha V, Devidas M, Valsecchi M, Gastier-Foster J, et al.
Lancet Haematol
. 2023 Jul;
10(7):e510-e520.
PMID: 37407142
Background: The outcome of children with Philadelphia chromosome-positive (Ph-positive) acute lymphoblastic leukaemia significantly improved with the combination of imatinib and intensive chemotherapy. We aimed to investigate the efficacy of dasatinib,...
7.
Brady S, Roberts K, Gu Z, Shi L, Pounds S, Pei D, et al.
Nat Genet
. 2022 Sep;
54(9):1376-1389.
PMID: 36050548
Acute lymphoblastic leukemia (ALL) is the most common childhood cancer. Here, using whole-genome, exome and transcriptome sequencing of 2,754 childhood patients with ALL, we find that, despite a generally low...
8.
Yang H, Zhang H, Luan Y, Liu T, Yang W, Roberts K, et al.
Nat Genet
. 2022 Feb;
54(2):170-179.
PMID: 35115686
Inherited noncoding genetic variants confer significant disease susceptibility to childhood acute lymphoblastic leukemia (ALL) but the molecular processes linking germline polymorphisms with somatic lesions in this cancer are poorly understood....
9.
Hunter J, Massingham L, Manickam K, Bartholomew D, Williamson R, Schwab J, et al.
Cold Spring Harb Mol Case Stud
. 2022 Jan;
8(2).
PMID: 35091509
Alterations in the gene have recently emerged as the cause of developmental delay with or without intellectual impairment or behavioral abnormalities (MIM # 619575). The 32 cases currently described in...
10.
Akhavanfard S, Nohr E, AlNajjar M, Haughn M, Hashimoto S, Deeg C, et al.
Case Rep Oncol
. 2021 May;
14(1):585-591.
PMID: 33976638
Neuroblastoma is the most common cancer in infants younger than 12 months of age, occurring with an incidence of 1 in 100,000 children. The clinical outcome of neuroblastoma ranges from...